After a decade of annual dose mass ivermectin treatment in Cameroon and Uganda, onchocerciasis transmission continues

Tropical Medicine and International Health

Volumn 13, Issue 9, 2008, Pages 1196-1203

  Katabarwa, Moses ^a,g   Eyamba, Albert ^a   Habomugisha, Peace ^b   Lakwo, Tom ^c   Ekobo, Same ^d   Kamgno, Joseph ^e   Kuete, Thomas ^d   Ndyomugyenyi, Richard ^c   Onapa, Ambrose ^c   Salifou, Mkpouwoueiko ^f   Ntep, Marcelline ^f   Richards, Frank O ^a  

^a CARTER CENTER   (United States)

^b Carter Center Uganda   (Uganda)

^c MINISTRY OF HEALTH   (Uganda)

^d UNIVERSITY OF YAOUNDÉ I   (Cameroon)

^e Filariasis Research Centre   (Cameroon)

^f Ministry of Health   (Cameroon)

^g EMORY UNIVERSITY   (United States)

Author keywords

Ivermectin; Onchocerciasis; Prevalence; Single annual dose; Transmission

Indexed keywords

IVERMECTIN;

BASELINE SURVEY; DISEASE PREVALENCE; DISEASE TRANSMISSION; DISEASE TREATMENT; HISTOLOGY; INVERTEBRATE; IVERMECTIN; ONCHOCERCIASIS;

ADOLESCENT; ADULT; ARTICLE; CAMEROON; CHILD; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DATA ANALYSIS; DISEASE CARRIER; DRUG EFFICACY; EMBRYO; ENDEMIC DISEASE; EXCISION; FEMALE; HEALTH SURVEY; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL EXAMINATION; MICROFILARIA; NONHUMAN; ONCHOCERCIASIS; PREVALENCE; SINGLE DRUG DOSE; STATISTICAL SIGNIFICANCE; SUBCUTANEOUS NODULE; UGANDA; WORM;

ADOLESCENT; ADULT; ANIMALS; CAMEROON; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; DRUG ADMINISTRATION SCHEDULE; ENDEMIC DISEASES; FEMALE; FILARICIDES; HUMANS; INFANT; IVERMECTIN; MALE; ONCHOCERCIASIS; SENTINEL SURVEILLANCE; TREATMENT OUTCOME; UGANDA;

AFRICA; CAMEROON; EAST AFRICA; SUB-SAHARAN AFRICA; UGANDA; WEST AFRICA;

EID: 50049101054     PISSN: 13602276     EISSN: 13653156     Source Type: Journal    
DOI: 10.1111/j.1365-3156.2008.02126.x     Document Type: Article

References (26)

1. Albiez EJ, Büttner DW Duke BO (1988) Diagnosis and extirpation of nodules in human onchocerciasis. Tropical Medicine and Parasitology 39 (Suppl. 4 331 346.
2. Amazigo U Boatin B (2006) The future of onchocerciasis control in Africa. Lancet 368, 1947.
3. Amazigo UV, Brieger WR, Katabarwa M et al. (2002) The challenges of community-directed treatment with ivermectin (CDTI) within the African Programme for Onchocerciasis Control (APOC). Annals of Tropical Medicine and Parasitology 96, S75 S92.
4. Boatin BA, Hougard JM, Alley ES et al. (1998) The impact of Mectizan on the transmission of onchocerciasis. Annals of Tropical Medicine and Parasitology 92, S46 60.
5. Boatin BA, Toe L, Alley ES et al. (2002) Detection of Onchocerca volvulus infection in low prevalence areas: a comparison of three diagnostic methods. Parasitology 125, 545 552.
6. Borsboom GJJM, Boatin AB, Nagelkerke NJD et al. (2003) Impact of ivermectin on onchocerciasis transmission: assessing the empirical evidence that repeated ivermectin mass treatment may lead to elimination/eradication in West Africa. Filaria Journal 2, 8.
7. Chippaux JP, Boussinesq M Prod'hon J (1995) The use of ivermectin in the control of onchocerciasis. Sante 5, 149 158.
8. Dadzie Y, Neira M Hopkins D (2003) Final report of the conference on the eradicability of Onchocerciasis. Filaria Journal 2, 2.
9. Duke BO, Marty AM, Peet DL et al. (2002) Neoplastic change in Onchocerca volvulus and its relation to ivermectin treatment. Parasitology 125, 431 444.
10. Hopkins DR, Richards FO Katabarwa M (2005) Whither onchocerciasis control in Africa. American Journal of Tropical Medicine and Hygiene 72, 1 2.
11. Katabarwa M, Onapa AW Nakileza B (1999) Rapid epidemiological mapping of onchocerciasis in areas of Uganda where Simulium neavei sl is the vector. East African Medical Journal 76, 440 446.
12. Katabarwa MN, Habomugisha P Agunyo S (2002) Involvement and performance of women in community-directed treatment with ivermectin for onchocerciasis control in Rukungiri District, Uganda. Health and Social Care in the Comminity 10, 382 393.
13. Katabarwa M, Lakwo T, Habumogisha P et al. (2008) Could neurocysticercosis be the cause of onchocerciasis-associated' epileptic seizures? American Journal of Tropical Medicine and Hygiene 78, 400 401.
14. Mas J, Ascaso C, Escaramis G et al. (2006) Reduction in the prevalence and intensity of infection in Onchocerca volvulus microfilariae according to ethnicity and community after 8 years of ivermectin treatment on the island of Bioko, Equatorial Guinea. Tropical Medicine and International Health 11, 1082 1091.
15. Molyneux DH Davies JB (1997) Onchocerciasis control: moving towards the millennium. Parasitology Today 13, 418 425.
16. Ndyomugyenyi R, Tukesiga E, Buttner DW et al. (2004) The impact of ivermectin treatment alone and when in parallel with Simulium neavei elimination on of onchocerciasis in Uganda. Journal of Tropical Medicine and International Health 9, 882 886.
17. Ngoumou P, Walsh JF Mace JM (1994) A rapid mapping technique for the prevalence and distribution of onchocerciasis: a Cameroon case study. Annals of Tropical Medicine and Parasitology 88, 463 474.
18. Osei-Atweneboana MY, Eng JK, Boakye DA et al. (2007) Prevalence and intensity of Onchocerca volvulus infection and efficacy of ivermectin in endemic communities in Ghana: a two-phase epidemiological study. Lancet 16, 2021 2029.
19. Prost A Prod'hon J (1978) Le diagnostique parasitologique de l'onchocercose. Revue critique des méthods en usage. Médicine Tropicale 38, 519 532.
20. Remme JHF (2004) Research for control: the onchocerciasis experience. Tropical Medicine and International Health 9, 243 254.
21. Remme J, De Sole G, Dadzie KY et al. (1990) Large scale ivermectin distribution and its epidemiological consequences. Acta Leidensia 59, 177 191.
22. Richards F, Hopkins D Cupp E (2000) Programmatic goals and approaches to onchocerciasis. Lancet 355, 1663 1664.
23. Rodriguez-Perez MA Reyes-Villanueva F (1994) The effect of ivermectin on the transmission of Onchocerca volvulus in southern Mexico. Salud Publica de Mexico, Instituto Nacional de Salud Publica 36, 281 290.
24. Taylor HR, Pacque M, Munoz B et al. (1990) Impact of mass treatment of onchocerciasis with ivermectin on the transmission of infection. Science 250, 116 118.
25. WHO Report (1991) Strategies for Ivermectin Distribution Through Primary Health Care System. (WHO/PHL/91.24) WHO, Geneva.
26. Winnen M, Plaisier AP, Alley ES et al. (2002) Can ivermectin mass treatments eliminate onchocerciasis in Africa? Bulletin of World Health Organization 80, 384 391.